Synchrony Financial unveils $6.5B buyback plan and dividend hike
Synchrony Financial (NYSE:SYF) today announced a major acceleration of its capital return program in conjunction with its first-quarter 2026 financial results.
Synchrony Financial (NYSE:SYF) today announced a major acceleration of its capital return program in conjunction with its first-quarter 2026 financial results.
VAALCO Energy (NYSE:EGY) released a comprehensive operational update today, highlighting significant production gains in Gabon and a major logistics success in Côte d’Ivoire.
Rox Resources (ASX:RXL) intercepted the United North mineralised shear zone at its flagship Youanmi Gold Project.
Ardiden (ASX:ADV) hits high-grade gold at its Astoria deposit in Québec, confirming a large-scale hydrothermal system.
Mineral Resources (ASX:MIN) has priced a US$1.3 billion dual-tranche senior unsecured notes offering.
Invion (ASX:IVX) announced the expansion of its clinical trial for INV043, moving into the final stage of its current non-melanoma skin cancer study.
The Australian Competition and Consumer Commission has launched a high-stakes legal battle against Woolworths (ASX:WOW) in the Federal Court.
Recce Pharmaceuticals (ASX:RCE) achieves a regulatory milestone as Indonesia's BPOM clears its Phase 3 clinical trial site for diabetic foot infection treatment.
Starpharma (ASX:SPL) achieved a regulatory milestone following a Type C guidance meeting with the US FDA.
Future Fund appoints external lawyers to investigate whistleblower claims regarding procurement and "cavalier" spending of taxpayer assets.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
